VEGFA and myocardial infarction: Transthoracic echocardiographyrevealed no significant differences prior to MI treatment in all groups.At the 8 week time point after treatment, EDA and ESA were significantlysmaller, and % FAC was significantly greater for the patch-VEGF group compared with thepatch and control groups (EDA: 45.8 ± 1.5 vs 56.8 ± 2.1vs 75.6 ± 2.3 mm2, ESA: 31.2 ± 1.6 vs 41.4 ±1.7 vs 62.8 ± 2.5 mm2, %FAC: 32.2 ± 1.4 vs 27.1± 0.4 vs 17.1 ± 1.4%, patch-VEGF vs patch vs control, p < 0.03, respectively) (Figure 3A–C).